New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
08:30 EDTALXNAlexion weakness would be buying opportunity, says Deutsche Bank
Deutsche Bank believes any weakness in shares of Alexion from the company's FDA warning letter would be a buying opportunity. Deutsche thinks the letter will not be impactful to Soliris and points out the company has sufficient inventory on hand.
News For ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2015
05:28 EDTALXNAlexion receives approval for updates to EU label for Solaris
Subscribe for More Information
April 7, 2015
17:38 EDTALXNAlexion CEO Dr. Leonard Bell retired as of March 31
Dr. Leonard Bell, the principal founder and CEO of Alexion Pharmaceuticals retired from Alexion effective March 31, after serving as CEO for twenty-three years. No severance was paid to Dr. Bell in connection with his retirement. On April 1, Alexion entered into a Consulting Agreement and a Letter Agreement with Dr. Bell. Dr. Bell continues to serve as Alexion's Chairman of the Board of Directors.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use